Glucocorticoid sparing in sarcoidosis using the Janus kinase (JAK) inhibitor tofacitinib.

Eur J Intern Med ; 98: 119-121, 2022 Apr.

Article in English | MEDLINE | ID: covidwho-1778104

Subject(s)

Janus Kinase Inhibitors; Sarcoidosis; Glucocorticoids; Humans; Janus Kinase Inhibitors/therapeutic use; Janus Kinases; Piperidines; Protein Kinase Inhibitors/therapeutic use; Pyrimidines; Sarcoidosis/drug therapy

Keywords

Granulomatosis; JAK inhibitor; Tofacitinib; corticosteroids; sarcoidosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sarcoidosis / Janus Kinase Inhibitors Limits: Humans Language: English Journal: Eur J Intern Med Journal subject: Internal Medicine Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google